Neonatal drug withdrawal syndrome Active Not Recruiting Phase 3 Trials for Morphine (DB00295)

Also known as: Drug withdrawal syndrome neonatal / Neonatal Abstinence Syndrome / Neonatal withdrawal symptoms from maternal use of drugs of addiction / Drug withdrawal syndrome in newborn / Withdrawal syndrome neonatal / Neonatal abstinence syndrome (disorder)

IndicationStatusPhase
DBCOND0101857 (Neonatal drug withdrawal syndrome)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03396588Non-Opiate Treatment After Prenatal Opiate Exposure to Prevent Postnatal Injury to the Young BrainTreatment